Macrogenics MGNX
NASDAQ MGNX
$4.40 +0.15 (+3.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Times Interest Earned (2023 - 2026)

Macrogenics (MGNX) posted quarterly Times Interest Earned of -$6.11 for Q1 2026, up 98.69% year-over-year from -$3.08 in Q1 2025, and down 115.92% quarter-over-quarter from -$2.83 in Q4 2025.

Analysis

Macrogenics (MGNX) Times Interest Earned (2023 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Times Interest Earned for 15 consecutive years, with -$6.11 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Times Interest Earned rose 98.69% year-over-year to -$6.11; the TTM figure through Mar 2026 stood at -$11.64 (up 99.15% YoY), while the FY2025 annual figure was -$8.56, down 3007.03% from the prior year.
  • Times Interest Earned declined to -$6.11 in Q1 2026 per MGNX's latest filing, from -$2.83 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $2201.5 in Q4 2024 and bottomed at -$9696.8 in Q2 2024.
  • Historically, Times Interest Earned has averaged -$737.65 across 5 years, with a median of -$6.11 in 2026.
  • Annual changes were most pronounced in 2024 — Times Interest Earned slumped 45039.17% — and 2025, when it jumped 99.53%.
  • Macrogenics' Times Interest Earned stood at -$73.71 in 2022, then soared by 70.86% to -$21.48 in 2023, then soared by 10348.27% to $2201.5 in 2024, then tumbled by 100.13% to -$2.83 in 2025, then slumped by 115.92% to -$6.11 in 2026.
  • Business Quant data shows MGNX's Times Interest Earned at -$6.11 in Q1 2026, -$2.83 in Q4 2025, and $5.58 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Macrogenics 284.90 Mn 171.00 Mn - -3.15
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.15
Mar 31, 2026 -6.84
Dec 31, 2025 -2.83
Sep 30, 2025 5.58
Jun 30, 2025 -53.90
Mar 31, 2025 -468.40
Dec 31, 2024 2,201.54
Jun 30, 2024 -9,696.83
Mar 31, 2024 -47.44
Jun 30, 2023 -58.09
Mar 31, 2023 -58.58